About Cigna Corporation
https://www.cigna.comThe Cigna Group provides insurance and related products and services in the United States. Its Evernorth segment provides a range of coordinated and point solution health services, including pharmacy, benefits management, care delivery and management, and intelligence solutions to health plans, employers, government organizations, and health care providers.
CEO
David Michael Cordani
Compensation Summary
(Year 2024)
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2007-06-05 | Forward | 3:1 |
| 1998-05-18 | Forward | 3:1 |
ETFs Holding This Stock
Summary
Showing Top 3 of 909
Ratings Snapshot
Rating : B+
Most Recent Analyst Grades
Raymond James
Strong Buy
TD Cowen
Buy
Goldman Sachs
Buy
Guggenheim
Buy
Truist Securities
Buy
UBS
Buy
Grade Summary
Showing Top 6 of 18
Price Target
Institutional Ownership
METATRON CAPITAL SICAV PLC
Shares:329.64M
Value:$89.33B
VANGUARD GROUP INC
Shares:25.76M
Value:$6.98B
BLACKROCK INC.
Shares:23.83M
Value:$6.46B
Summary
Showing Top 3 of 2,153
About Cigna Corporation
https://www.cigna.comThe Cigna Group provides insurance and related products and services in the United States. Its Evernorth segment provides a range of coordinated and point solution health services, including pharmacy, benefits management, care delivery and management, and intelligence solutions to health plans, employers, government organizations, and health care providers.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $69.75B ▲ | $3.36B ▼ | $1.87B ▲ | 2.68% ▲ | $7.02 ▲ | $3.34B ▲ |
| Q2-2025 | $67.23B ▲ | $5.45B ▲ | $1.53B ▲ | 2.28% ▲ | $5.76 ▲ | $3.04B ▼ |
| Q1-2025 | $65.5B ▼ | $4.63B ▲ | $1.32B ▼ | 2.02% ▼ | $4.88 ▼ | $3.06B ▲ |
| Q4-2024 | $65.65B ▲ | $4.29B ▲ | $1.42B ▲ | 2.17% ▲ | $5.13 ▲ | $2.94B ▼ |
| Q3-2024 | $63.69B | $4.03B | $739M | 1.16% | $2.65 | $3.29B |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $6.03B ▲ | $157.92B ▲ | $115.91B ▲ | $41.8B ▲ |
| Q2-2025 | $5.14B ▼ | $151.65B ▲ | $111.22B ▲ | $40.21B ▼ |
| Q1-2025 | $9.06B ▲ | $150.66B ▼ | $110.24B ▼ | $40.23B ▼ |
| Q4-2024 | $8.21B ▲ | $155.88B ▼ | $114.64B ▼ | $41.03B ▼ |
| Q3-2024 | $6.75B | $157.64B | $115.34B | $42.09B |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $1.87B ▲ | $3.42B ▲ | $-4.39B ▼ | $2.66B ▲ | $1.7B ▲ | $3.14B ▲ |
| Q2-2025 | $1.63B ▲ | $-1.89B ▼ | $-797M ▼ | $-1.33B ▲ | $-3.99B ▼ | $-2.17B ▼ |
| Q1-2025 | $1.41B ▼ | $1.92B ▼ | $1.2B ▲ | $-3.68B ▼ | $-555M ▼ | $1.59B ▼ |
| Q4-2024 | $1.54B ▲ | $5.21B ▲ | $-191M ▲ | $-3.25B ▼ | $1.75B ▲ | $4.88B ▲ |
| Q3-2024 | $825M | $46M | $-776M | $439M | $-273M | $-353M |
Revenue by Products
| Product | Q4-2024 | Q1-2025 | Q2-2025 | Q3-2025 |
|---|---|---|---|---|
 Cigna Healthcare | $20.99Bn ▲ | $13.17Bn ▼ | $10.80Bn ▼ | $10.93Bn ▲ |
 Evernorth | $95.99Bn ▲ | $52.00Bn ▼ | $57.83Bn ▲ | $60.39Bn ▲ |
CEO
David Michael Cordani
Compensation Summary
(Year 2024)
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2007-06-05 | Forward | 3:1 |
| 1998-05-18 | Forward | 3:1 |
ETFs Holding This Stock
Summary
Showing Top 3 of 909
Ratings Snapshot
Rating : B+
Most Recent Analyst Grades
Raymond James
Strong Buy
TD Cowen
Buy
Goldman Sachs
Buy
Guggenheim
Buy
Truist Securities
Buy
UBS
Buy
Grade Summary
Showing Top 6 of 18
Price Target
Institutional Ownership
METATRON CAPITAL SICAV PLC
Shares:329.64M
Value:$89.33B
VANGUARD GROUP INC
Shares:25.76M
Value:$6.98B
BLACKROCK INC.
Shares:23.83M
Value:$6.46B
Summary
Showing Top 3 of 2,153